Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies

Clinical trial NCT00079391 · COMPLETED

Trial details

NCT number: NCT00079391
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hematologic Malignancies Bone Marrow Transplant Rejection

Start date: 2004-01-01
Primary completion: 2008-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.